ARCHIVES

DCE Board Approves Concept For studies Of Thorotrast Exposure

This article is from The Cancer Letter archive.

Vol. 16 No. 44 | November 16, 1990

Download PDF Visit The Full Archive

Related Articles

Four RFAs Released For RM Program

November 6, 1981

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening

September 21, 1990

Cancer Program Depend On Vitality Of Centers, Broder ells DCPC Board

May 12, 1989

Bristol-Myers Awards 42.5 Million In Cancer Grants

October 21, 1977